Global Scale Leverage Nova's global IVD leadership and post-merger expansion to upsell integrated instrument suites across clinical diagnostics, biotech processing, and veterinary analytics, targeting customers seeking end-to-end life sciences tools and cross-portfolio deployments.

Innovation Pipeline Capitalize on a robust R&D-driven roadmap to drive upgrades and new platform adoption, promoting advanced blood gas, cell culture monitoring, and automated analytics that deliver faster, more reliable decision support.

Strategic Partnerships Leverage existing collaborations and ecosystem ties to offer interoperable solutions that fit biopharma, hospitals, and diagnostics networks, increasing cross-sell opportunities and leveraging co-developed data and trials.

Secure & Compliant Highlight cybersecurity resilience and HIPAA-compliant data handling as differentiators, offering secure instrument software, encrypted data transfer, and audit-ready reporting to address customer risk concerns.

Trusted Leader Market Nova as the largest privately held IVD company in the US with a loyal customer base and broad geographic reach, emphasizing service excellence, multi-site deployments, and flexible partnerships to win enterprise deals.